Zomato CEO Deepinder Goyal Claps Back at 'Temple' Device Critics

• Deepinder Goyal responded to backlash regarding 'Temple', a health monitoring device seen on him during a podcast.
• Doctors and influencers questioned the device's credibility online, prompting Goyal to clarify it's not yet public.
• Goyal stated no commercial announcements or official benchmarking data have been released for 'Temple'.
• He highlighted the irony of advising against an 'unvalidated' device not yet available for purchase.
• Goyal assured transparency and shared scientific details if and when the product is launched commercially.

Why It Matters: Zomato CEO Deepinder Goyal defends his 'Temple' device, stating it's not yet public or validated.